The Securities and Exchange Commission today charged Georgia-based biotech company MiMedx Group Inc. and three former top executives with defrauding investors by misstating the company’s revenue and attempting to cover up their misconduct. MiMedx has…
Read the Full Press Release
Have a securities law question? Call Sallah Astarita & Cox at 212-509-6544.
